Study provides new look at why rare cancer often evades treatments

Por um escritor misterioso

Descrição

Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study provides new look at why rare cancer often evades treatments
Gene Therapy: A New Frontier in Disease-Modifying Therapies
Study provides new look at why rare cancer often evades treatments
Using genomics to guide personalized cancer treatment
Study provides new look at why rare cancer often evades treatments
Biomolecules, Free Full-Text
Study provides new look at why rare cancer often evades treatments
The Possibilities and Risks of Genetically Altering Immune Cells to Fight Cancer, Science
Study provides new look at why rare cancer often evades treatments
Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers - ScienceDirect
Study provides new look at why rare cancer often evades treatments
Study provides new look at why rare cancer often evades treatments
Study provides new look at why rare cancer often evades treatments
What is microsatellite instability?
Study provides new look at why rare cancer often evades treatments
LATEST BREAKTHROUGHS IN TREATMENT FOR GLIOBLASTOMA
Study provides new look at why rare cancer often evades treatments
Frontiers Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies
Study provides new look at why rare cancer often evades treatments
Hope for breast cancer patients, but with a cruel caveat — Harvard Gazette
Study provides new look at why rare cancer often evades treatments
A New Way of Looking at Cancer
de por adulto (o preço varia de acordo com o tamanho do grupo)